Dublin, Sept. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Healthcare Contract Development & Manufacturing Organization Market (2021-2026) by services, Geography, Competitive Analysis and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
The Global Healthcare Contract Development & Manufacturing Organization Market is estimated to be USD 209.5 Bn in 2021 and is expected to reach USD 314.8 Bn by 2026, growing at a CAGR of 8.5 %.
Key factors, such as the growing number of new molecular entities have led to a demand for high-end technical expertise. Also, at given times, to expedite the drug manufacturing process, pharma companies are depending on CDMOs for their niche technical expertise to get the product in the market.
In addition to it, companies are equally focusing on reducing the capital expenditure involved in manufacturing processes. These factors are prominently driving the growth of the contract development and manufacturing organization (CDMO) market.
However, the serialization issues along with the infringement issues related to intellectual property are likely to restrain the market growth.
The Global Healthcare Contract Development & Manufacturing Organization Market is segmented further based on services and Geography.
By Services, the market is classified as contract development and contract manufacturing. Amongst the two, the contract manufacturing segment is estimated to hold the highest market share.
By Geography, North America is projected to lead the market.
Moderna, Inc and Recipharm AB, a CDMO have drafted an agreement to support the formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside the U.S. - 30th December 2020
Siegfried has acquired two pharmaceutical manufacturing sites from Novartis based out of Spain. This is in view towards creating a center of excellence for the sites' current technology portfolio in the Barcelona region. - 29th September 2020
Some of the companies covered in this report are
Almac Group Ltd.
Baxter International, Inc.
B. Braun Melsungen AG
Boehringer Ingelheim International GmbH
Cambrex Corp. (Permira Funds)
Hisun Pharmaceuticals Inc.
Jubilant Life Sciences Ltd.
IQVIA Holdings Inc
Lonza Group Ltd.
Mikart LLC (Nautic Partners)
Probiogen AG (Minapharm Pharmaceuticals)
Siegfried Holding AG
Stason Pharmaceuticals, Inc.
Thermo Fisher Scientific Inc.
Key Topics Covered:
1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.4 Years Considered
1.6 Key Shareholders
2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study
3 Executive Summary
4 Market Overview
4.2 Market Dynamics
22.214.171.124 Need of a high-level expertise to expedite drug manufacturing process
126.96.36.199 Focus of the pharmaceutical companies towards reducing their operational expenses
188.8.131.52 Increasing complexity with the development of new molecular entities
184.108.40.206 Serialization issues faced by healthcare organizations
220.127.116.11 Issues related to infringement of Intellectual Property (IP) rights
18.104.22.168 Rise in the drug approvals cases
22.214.171.124 Technological Advancements
126.96.36.199 Increasing collaborations and investments by CDMOs
188.8.131.52 Compliance issues while outsourcing
5 Market Analysis
5.1 Porter's Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis
6 Global Healthcare Contract Development & Manufacturing Organization Market, By Service
6.2 Contract Development
184.108.40.206 Bioanalysis and DMPK studies
220.127.116.11 Toxicology Testing
18.104.22.168 Other Preclinical Services
22.214.171.124 Phase I
126.96.36.199 Phase II
188.8.131.52 Phase III
184.108.40.206 Phase IV
6.2.3 Laboratory Services
220.127.116.11 Bioanalytical Services
18.104.22.168 Analytical Services
6.3 Contract Manufacturing
6.3.1 API/Bulk Drugs
6.3.2 Finished Dose Formulations
6.3.3 Medical Device
22.214.171.124 Class I
126.96.36.199 Class II
188.8.131.52 Class III
7 Global Healthcare Contract Development & Manufacturing Organization Market, By Solution Type
8 Competitive Landscape
8.1 Competitive Quadrant
8.2 Market Share Analysis
8.3 Competitive Scenario
8.3.1 Mergers & Acquisitions
8.3.2 Agreement, Collaborations, & Partnerships
8.3.3 New Product Launches & Enhancements
8.3.4 Investments & Fundings
9 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/4x58pj
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900